News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,889 Results
Type
Article (14415)
Company Profile (105)
Press Release (260361)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88510)
Career Advice (476)
Deals (15410)
Drug Delivery (73)
Drug Development (36972)
Employer Resources (50)
FDA (6414)
Job Trends (6268)
News (151176)
Policy (14175)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (455)
Accelerated approval (14)
Adcomms (9)
Allergies (68)
Alliances (23413)
ALS (57)
Alzheimer's disease (629)
Antibody-drug conjugate (ADC) (99)
Approvals (6609)
Artificial intelligence (203)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4404)
BIOSECURE Act (9)
Biosimilars (119)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1320)
Cardiovascular disease (153)
Career advice (429)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (151)
Cervical cancer (9)
Clinical research (32180)
Collaboration (729)
Compensation (325)
Complete response letters (34)
COVID-19 (786)
CRISPR (43)
C-suite (433)
Cystic fibrosis (58)
Data (1842)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1387)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (81)
Earnings (33546)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39183)
Executive appointments (529)
FDA (7528)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (431)
Gene editing (70)
Generative AI (19)
Gene therapy (166)
GLP-1 (446)
Government (1410)
Grass and pollen (5)
Guidances (164)
Healthcare (3646)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (70)
Immuno-oncology (14)
Indications (53)
Infectious disease (850)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5921)
IRA (33)
Job creations (2058)
Job search strategy (377)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (208)
Leadership (9)
Legal (3454)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (124)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1322)
Medtech (1329)
Mergers & acquisitions (9909)
Metabolic disorders (435)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (96)
Neuropsychiatric disorders (37)
Neuroscience (1042)
Neurotech (1)
NextGen: Class of 2026 (1603)
Non-profit (624)
Now hiring (17)
Obesity (228)
Opinion (141)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (83)
Partnered (11)
Patents (221)
Patient recruitment (117)
Peanut (12)
People (29794)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8343)
Phase 2 (13580)
Phase 3 (12294)
Pipeline (1923)
Policy (135)
Postmarket research (1403)
Preclinical (3350)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (353)
Real estate (2664)
Recruiting (18)
Regulatory (11006)
Reports (15)
Research institute (577)
Resumes & cover letters (65)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (80)
Series B (49)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (84)
Sponsored (9)
Startups (1648)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (233)
Venture capital (32)
Weight loss (141)
Women's health (27)
Worklife (4)
Date
Last 7 days (178)
Last 30 days (707)
Last 365 days (10476)
2026 (955)
2025 (10785)
2024 (12594)
2023 (14349)
2022 (19671)
2021 (20220)
2020 (19084)
2019 (14971)
2018 (11780)
2017 (13917)
2016 (13165)
2015 (15511)
2014 (12442)
2013 (10606)
2012 (11440)
2011 (11962)
2010 (10916)
Location
Africa (323)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20961)
Australia (2691)
California (3196)
Canada (1487)
China (550)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40969)
Florida (607)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (348)
India (44)
Indiana (241)
Iowa (2)
Japan (260)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (423)
Massachusetts (2632)
Michigan (46)
Minnesota (166)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1403)
New Mexico (7)
New York (917)
North Carolina (621)
North Dakota (2)
Northern California (1455)
Ohio (85)
Oklahoma (5)
Oregon (19)
Pennsylvania (719)
Puerto Rico (12)
Rhode Island (17)
South America (511)
South Carolina (10)
Southern California (1393)
Tennessee (53)
Texas (455)
United States (12774)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (223)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,889 Results for "aria pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
American Liver Foundation Hosts the 34th Annual Irwin M. Arias Symposium
December 2, 2025
·
7 min read
Press Releases
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
December 10, 2025
·
10 min read
BioMidwest
Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System
Aria CV, Inc today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System as part of the ASPIRE PH clinical trial at Ascension St. Vincent Cardiovascular Research Institute in Indianapolis, Indiana.
February 27, 2024
·
3 min read
Press Releases
Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer’s Disease Patients in Phase 3b study
October 29, 2024
·
11 min read
Press Releases
Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H
September 3, 2024
·
3 min read
Press Releases
icometrix is proud to announce the market approval of icobrain aria, the first market-approved solution for monitoring amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease
September 4, 2024
·
7 min read
Press Releases
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
January 27, 2025
·
12 min read
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria®.
November 29, 2023
·
8 min read
Drug Development
Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates
Aria Pharmaceuticals secured six provisional patents to cover the lead drug candidates for its lupus, idiopathic pulmonary fibrosis and chronic kidney disease research programs.
August 30, 2022
·
2 min read
·
Alex Keown
Press Releases
Cortechs.ai Receives a New NIH Grant for ARIA Detection in Alzheimer’s Disease
July 31, 2024
·
2 min read
1 of 27,489
Next
